A new tool for improving quality control in DNA sequencing
Official title: A Novel Instrument and Consumables for Quality Control in Next Generation Sequencing
Funded at Evizia INC · NIH-11066862 · Data updated 2026-11-12
This study is testing a new imaging system that helps make DNA testing faster and more accurate, which could lead to quicker and more reliable results for patients needing genetic testing.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Evizia INC NIH-funded |
| Lab location | 1 site (Midlothian, UNITED STATES) |
| Project start | April 7, 2025 |
| Project end | March 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $1,234,692 |
| NIH project number | 1R44HG014079-01 |
| Project ID | NIH-11066862 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals undergoing genetic testing or those with conditions that require precise DNA analysis.
✕Less likely to help
Patients who do not require genetic testing or whose conditions are unrelated to DNA sequencing may not benefit from this research.
What this research studies
This research focuses on developing a novel imaging system that enhances the quality control process for next-generation sequencing (NGS) of DNA. By utilizing High-Speed Atomic Force Microscopy (HSAFM), the system allows for rapid and precise analysis of DNA samples, significantly improving the accuracy and efficiency of the sequencing process. Patients may benefit from this advancement as it could lead to faster and more reliable genetic testing results, which are crucial for personalized medicine and treatment decisions.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate genetic testing, improving patient outcomes in personalized medicine.
How similar studies have gone: Other research has shown success with advanced imaging techniques in molecular biology, suggesting that this approach has the potential for significant advancements in DNA analysis.
Where this research is happening
-
Evizia INC
Midlothian, United States Active
Researchers
- Principal investigator: Reed, Jason C — Evizia INC
- Study coordinator: Reed, Jason C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.